The draft amendments to the Requirements for stability testing of drugs and pharmaceutical substances applies to put into circulation on the territory of the Eurasian economic Union drugs and calls for the unified approach to the definition of "production date of the series" in order to exclude the possibility of automatic updates of the shelf life of the pharmaceutical substance by a simple repackaging, and the calculation of the shelf life of finished drugs, issued in circulation in the customs territory of the Eurasian economic Union for the purpose of elimination of the possibility of automatic renewal of the shelf life of the pharmaceutical substance by its simple repackaging, as well as the use in the production of substances with an expiration date not corresponding to the shelf life of finished drugs, which may lead to inconsistencies of expert reports and recognition.
The draft guide has been prepared in order to:
- protection of life and health of the patient (as the final consumer of medicines);
- protection of the interests of the health care system as a whole (as the primary consumer of medicines)
- protection of the interests of the authorized bodies (expert organizations) that perform the procedure of evaluation of the registration dossier of the drug from the position of proof of its compliance with the specified quality standard.